QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.018945v1 69/5/1542    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, H. Articles by Unadkat, J. D. Search for Related Content PubMed PubMed Citation Articles by Hu, H. Articles by Unadkat, J. D. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Compound via MeSH Substance via MeSH

Electrophysiological Characterization and Modeling of the Structure Activity Relationship of the Human Concentrative Nucleoside Transporter 3 (hCNT3)

Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia (H.H., N.S.U., Y-J.F., S.I., V.G.); Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland (C.C., P.W.S.); and Department of Pharmaceutics, University of Washington, Seattle, Washington (C.J.E., E-W.L., J.D.U.)

We characterized the electrophysiology, kinetics, and quantitative structure-activity relationship (QSAR) of the human concentrative nucleoside transporter 3 (hCNT3) expressed in Xenopus laevis oocytes by measuring substrate-induced inward currents using a two-microelectrode voltage-clamp system. At membrane potentials between -30 and -150 mV, sodium activation of gemcitabine transport was sigmoidal, with a K_0.5 of 8.5 ± 0.3 mM for Na⁺ and a Hill coefficient of 2.2 ± 0.25 independent of membrane potential. We measured the I_max and K_0.5 for substrate at -50 mV for the nucleoside analog drugs gemcitabine (638 ± 58 nA, 59.7 ± 17.5 µM), ribavirin (546 ± 37 nA, 61.0 ± 13.2 µM), AZT (420 ± 4 nA, 310 ± 9 µM), and 3-deazauridine (506 ± 30 nA, 50.8 ± 9.90 µM). K_0.5 and I_max for substrate were dependent on membrane potential (both increasing as the membrane became more hyperpolarized) for all four drugs. hCNT3 also exhibited pre-steady-state currents. The quantitative structure-activity relationship (QSAR) was examined using comparative molecular field analysis and comparative molecular similarity indices analysis of the inward currents induced by 27 nucleoside analogs with substitutions at both the ribose and the nucleobase. Two statistically significant QSAR models identified electrostatic interaction as the major force in hCNT3 transport and attributed a critical role to the 3'-hydroxyl position of hCNT3 substrates. Steric hindrance at the 3-position and positive charge at the 5-position of the pyrimidine ring were favorable for transport. Two hCNT3 pharmacophore models revealed the minimal features required for hCNT3 transport as two hydrogen bond acceptors at 3'-OH and 5'-O and the hydrophobic center occupied by the base ring.

Received for publication September 28, 2005.

Accepted for publication January 30, 2006.

Address correspondence to: Dr. Jashvant D. Unadkat, Department of Pharmaceutics, Box 357610, University of Washington, Seattle, WA 98195. E-mail: jash{at}u.washington.edu

This article has been cited by other articles:

				C. J. Endres, A. M. Moss, R. Govindarajan, D.-S. Choi, and J. D. Unadkat The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(-/-) Mice J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 287 - 296. [Abstract] [Full Text] [PDF]

				D. E. Johnson, H.-w. Ai, P. Wong, J. D. Young, R. E. Campbell, and J. R. Casey Red Fluorescent Protein pH Biosensor to Detect Concentrative Nucleoside Transport J. Biol. Chem., July 31, 2009; 284(31): 20499 - 20511. [Abstract] [Full Text] [PDF]

				E. Errasti-Murugarren, M. Molina-Arcas, F. J. Casado, and M. Pastor-Anglada A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum FASEB J, January 1, 2009; 23(1): 172 - 182. [Abstract] [Full Text] [PDF]

				R. Govindarajan, C. J. Endres, D. Whittington, E. LeCluyse, M. Pastor-Anglada, C.-M. Tse, and J. D. Unadkat Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G570 - G580. [Abstract] [Full Text] [PDF]

				M. D. Slugoski, A. M. L. Ng, S. Y. M. Yao, K. M. Smith, C. C. Lin, J. Zhang, E. Karpinski, C. E. Cass, S. A. Baldwin, and J. D. Young A Proton-mediated Conformational Shift Identifies a Mobile Pore-lining Cysteine Residue (Cys-561) in Human Concentrative Nucleoside Transporter 3 J. Biol. Chem., March 28, 2008; 283(13): 8496 - 8507. [Abstract] [Full Text] [PDF]

				I. Markovic, M. Segal, B. Djuricic, and Z. Redzic Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ Exp Physiol, March 1, 2008; 93(3): 325 - 333. [Abstract] [Full Text] [PDF]

				G. Minuesa, S. Purcet, I. Erkizia, M. Molina-Arcas, M. Bofill, N. Izquierdo-Useros, F. J. Casado, B. Clotet, M. Pastor-Anglada, and J. Martinez-Picado Expression and Functionality of Anti-Human Immunodeficiency Virus and Anticancer Drug Uptake Transporters in Immune Cells J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 558 - 567. [Abstract] [Full Text] [PDF]

				E. Errasti-Murugarren, P. Cano-Soldado, M. Pastor-Anglada, and F. J. Casado Functional Characterization of a Nucleoside-Derived Drug Transporter Variant (hCNT3C602R) Showing Altered Sodium-Binding Capacity Mol. Pharmacol., February 1, 2008; 73(2): 379 - 386. [Abstract] [Full Text] [PDF]